Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $153,009 (100.0% shares, 0.0% debt)

Holdings (5)

PHVS Pharvaris N.V. 53.2%

Value ($000) $81,449 Shares 4,397,881 Est. Cost $27.29 Unrealized -33.0%

KURA Kura Oncology, Inc. 23.6%

Value ($000) $36,148 Shares 1,849,947 Est. Cost $20.39 Unrealized -0.6%

SNDX Syndax Pharmaceuticals, Inc. 11.0%

Value ($000) $16,844 Shares 875,000 Est. Cost $22.62 Unrealized -8.7%

— Lyell Immunopharma, Inc. 7.5%

Value ($000) $11,489 Shares 8,325,000 Est. Cost $16.24 Unrealized —

RLAY Relay Therapeutics Inc. 4.6%

Value ($000) $7,080 Shares 1,000,000 Est. Cost $7.47 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,397,881	$81,449	53.2%	$27.29	-33.0%	COM	N69605108
KURA	Kura Oncology, Inc.	1,849,947	$36,148	23.6%	$20.39	-0.6%	COM	50127T109
SNDX	Syndax Pharmaceuticals, Inc.	875,000	$16,844	11.0%	$22.62	-8.7%	COM	87164F105
—	Lyell Immunopharma, Inc.	8,325,000	$11,489	7.5%	$16.24	—	COM	55083R104
RLAY	Relay Therapeutics Inc.	1,000,000	$7,080	4.6%	$7.47	0.0%	COM	75943R102